VEGFA and retinal vein occlusion: The consensus among retinal disease experts was that for neovascular AMD, retinal vein occlusion and diabetic retinopathy patients, anti-VEGF injection regimens should continue during lockdowns or curtailed non-urgent ophthalmic services [19].